Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Tower Co. stock logo
AMT
American Tower
$197.03
+0.9%
$185.16
$154.58
$219.10
$92.01B0.792.30 million shs1.93 million shs
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$25.31
-1.4%
$24.99
$21.52
$32.28
$11.06B0.8727,635 shs526,556 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Tower Co. stock logo
AMT
American Tower
+0.16%+1.41%+2.64%-0.14%+2.14%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
-1.42%-3.91%-1.52%-6.29%-19.83%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Tower Co. stock logo
AMT
American Tower
4.3537 of 5 stars
3.53.01.73.12.32.51.3
Smith & Nephew plc stock logo
SNN
Smith & Nephew
1.0153 of 5 stars
0.02.02.50.02.60.01.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Tower Co. stock logo
AMT
American Tower
2.91
Moderate Buy$220.9112.12% Upside
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.60
Moderate BuyN/AN/A

Current Analyst Ratings

Latest SNN, 4DX, ADR, and AMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/5/2024
Smith & Nephew plc stock logo
SNN
Smith & Nephew
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
5/30/2024
American Tower Co. stock logo
AMT
American Tower
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$234.00 ➝ $223.00
5/1/2024
American Tower Co. stock logo
AMT
American Tower
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Outperform ➝ Sector Outperform$243.00 ➝ $223.00
5/1/2024
American Tower Co. stock logo
AMT
American Tower
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$228.00 ➝ $220.00
5/1/2024
American Tower Co. stock logo
AMT
American Tower
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeOutperform ➝ Strong-Buy$226.00 ➝ $248.00
4/15/2024
American Tower Co. stock logo
AMT
American Tower
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$183.00 ➝ $196.00
4/8/2024
American Tower Co. stock logo
AMT
American Tower
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$205.00
(Data available from 6/15/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Tower Co. stock logo
AMT
American Tower
$11.14B8.26$9.92 per share19.86$23.30 per share8.46
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$5.55B1.99$3.17 per share7.99$11.94 per share2.12

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Tower Co. stock logo
AMT
American Tower
$1.48B$4.4244.5819.151.4018.42%18.45%3.11%7/25/2024 (Estimated)
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$263MN/A0.0012.111.15N/AN/AN/AN/A

Latest SNN, 4DX, ADR, and AMT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024Q1 2024
American Tower Co. stock logo
AMT
American Tower
$2.43$1.96-$0.47$1.96$2.79 billion$2.83 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Tower Co. stock logo
AMT
American Tower
$6.483.29%+12.50%146.61%N/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$0.903.56%N/AN/AN/A

Latest SNN, 4DX, ADR, and AMT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/23/2024
American Tower Co. stock logo
AMT
American Tower
quarterly$1.623.47%6/14/20246/14/20247/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Tower Co. stock logo
AMT
American Tower
3.39
0.85
0.85
Smith & Nephew plc stock logo
SNN
Smith & Nephew
0.44
1.77
0.72

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Tower Co. stock logo
AMT
American Tower
92.69%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
25.64%

Insider Ownership

CompanyInsider Ownership
American Tower Co. stock logo
AMT
American Tower
0.18%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
1.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Tower Co. stock logo
AMT
American Tower
5,643466.98 million466.13 millionOptionable
Smith & Nephew plc stock logo
SNN
Smith & Nephew
18,452437.17 million432.80 millionOptionable

SNN, 4DX, ADR, and AMT Headlines

Recent News About These Companies

Smith & Nephew (NYSE:SNN) Upgraded to Buy by UBS Group

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

American Tower logo

American Tower

NYSE:AMT
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.
Smith & Nephew logo

Smith & Nephew

NYSE:SNN
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.